Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Pasha, Zeeshan ^a   Haider, Husnain Kh ^a   Ashraf, Muhammad ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; N PHTHALOYLTRYPTOPHAN; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 1; BIOLOGICAL MARKER; DNA (CYTOSINE 5 ) METHYLTRANSFERASE 1; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; INDOLE DERIVATIVE; MICRORNA; PROPIONIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; CULTURE OPTIMIZATION; EMBRYOID BODY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; IMMUNOCOMPETENCE; IN VITRO STUDY; MALE; MOLECULAR LIBRARY; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; STEM CELL; TERATOMA; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DNA MICROARRAY; DRUG ANTAGONISM; DRUG EFFECT; EMBRYONIC STEM CELL; GENETICS; HEART CONTRACTION; HEART FUNCTION TEST; HEART MUSCLE; HEART VENTRICLE REMODELING; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; STEM CELL TRANSPLANTATION; ULTRASTRUCTURE; VIRUS;

IPS; MUS; MUS MUSCULUS;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EMBRYONIC STEM CELLS; HEART FUNCTION TESTS; INDOLES; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE; MICRORNAS; MYOBLASTS, SKELETAL; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; NUCLEAR REPROGRAMMING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROPIONIC ACIDS; STEM CELL TRANSPLANTATION; TERATOMA; VENTRICULAR REMODELING; VIRUSES;

EID: 80051728762     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023667     Document Type: Article

References (29)

1. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
2. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, et al. (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318: 1920-1923.
3. Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, et al. (2008) Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133: 250-264.
4. Wernig M, Meissner A, Cassady JP, Jaenisch R, (2008) c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2: 10-12.
5. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K, (2008) Induced pluripotent stem cells generated without viral integration. Science 322: 945-949.
6. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S, (2008) Generation of mouse induced pluripotent stem cells without viral vectors. Science 322: 949-953.
7. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, et al. (2009) Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458: 771-775.
8. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, et al. (2009) piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458: 766-770.
9. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, et al. (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26: 101-106.
10. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, et al. (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95: 379-391.
11. Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, et al. (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26: 1269-1275.
12. Shi Y, Desponts C, Do JT, Hahm HS, Schöler HR, et al. (2008) Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3: 568-574.
13. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, et al. (2008) Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 26: 795-797.
14. Brueckner B, Garcia Boy R, Siedlecki P, Musch T, Kliem HC, et al. (2005) Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Res 65: 6305-6311.
15. Wang Y, Haider HK, Ahmad N, Xu M, Ge R, et al. (2006) Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J Mol Cell Cardiol 40: 736-745.
16. Dann CT, Alvarado AL, Molyneux LA, Denard BS, Garbers DL, et al. (2008) Spermatogonial stem cell self-renewal requires OCT4, a factor downregulated during retinoic acid-induced differentiation. Stem Cells 26: 2928-2937.
17. Pardo M, Lang B, Yu L, Prosser H, Bradley A, et al. (2010) An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell 6: 382-395.
18. Buehr M, Nichols J, Stenhouse F, Mountford P, Greenhalgh CJ, et al. (2003) Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines. Biol Reprod 68: 222-229.
19. Haider H, Ye L, Jiang S, Ge R, Law PK, et al. (2004) Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor. J Mol Med 82: 539-349.
20. Jain M, DerSimonian H, Brenner DA, Ngoy S, Teller P, et al. (2001) Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 103: 1920-1927.
21. Menasche P, Hagege AA, Scorsin M, Pouzet B, Desnos M, et al. (2001) Myoblast transplantation for heart failure. Lancet 357: 279-280.
22. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, et al. (2008) Dissecting direct reprogramming through integrative genomic analysis. Nature 454: 49-55.
23. Han J, Sachdev PS, Sidhu KS, (2010) A combined epigenetic and non-genetic approach for reprogramming human somatic cells. PLoS One 5: e12297.
24. Han JW, Yoon YS, (2011) Induced Pluripotent Stem Cells: Emerging Techniques for Nuclear Reprogramming. Antioxid Redox Signal doi:10.1089/ars.2010.3814.
25. Watanabe S, Hirai H, Asakura Y, Tastad C, Verma M, et al. (2011) Myod Gene Suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells. Stem Cells 29: 505-516.
26. Ahmed RP, Ashraf M, Buccini S, Jiang S, Haider HK, (2011) Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction. Regen Med 6: 171-78.
27. Ahmed RP, Haider HK, Buccini S, Li L, Jiang S, et al. (2011) Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart. Cir Res 109: 60-70.
28. Stefani G, Slack F, (2006) MicroRNAs in search of a target. Cold Spring Harb Symp Quant Biol 71: 129-134.
29. Leung AK, Sharp PA, (2010) MicroRNA functions in stress responses. Mol Cell 40: 205-215.